We are live on ! Find out more
VC

Vivo Capital Portfolio holdings

AUM $1.2B
1-Year Est. Return 911.44%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+911.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.2B
AUM Growth
-$344M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$34M
2
+$20M
3
+$15.1M
4
SNSE icon
Sensei Biotherapeutics
SNSE
+$14.4M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$9.12M

Top Sells

1
+$211M
2
+$165M
3
+$73M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$57.8M
5
ZBIO
Zenas BioPharma
ZBIO
+$31M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ERAS icon
1
Erasca
ERAS
$4.37B
$197M 16.34%
12,151,480
+2,878,052
PRAX icon
2
Praxis Precision Medicines
PRAX
$7.43B
$109M 9.08%
338,895
+10,000
TERN
3
DELISTED
Terns Pharmaceuticals
TERN
$70.4M 5.85%
1,334,418
-4,012,510
TRVI icon
4
Trevi Therapeutics
TRVI
$2.02B
$60.8M 5.05%
5,094,668
DBVT
5
DBV Technologies
DBVT
$1.03B
$55.7M 4.63%
2,667,569
+205,943
CMPX icon
6
Compass Therapeutics
CMPX
$366M
$50.5M 4.2%
9,545,466
TNGX icon
7
Tango Therapeutics
TNGX
$5.04B
$45.1M 3.75%
2,154,780
SABS icon
8
SAB Biotherapeutics
SABS
$255M
$43.7M 3.64%
11,420,000
CRVS icon
9
Corvus Pharmaceuticals
CRVS
$1B
$41M 3.41%
2,805,816
+571,250
DRUG
10
Bright Minds Biosciences
DRUG
$598M
$40.7M 3.38%
557,172
+55,555
SVA
11
DELISTED
Sinovac Biotech, Ltd
SVA
$38.2M 3.17%
5,903,000
DNTH icon
12
Dianthus Therapeutics
DNTH
$4.49B
$29.7M 2.47%
353,998
DYN icon
13
Dyne Therapeutics
DYN
$3.01B
$28.2M 2.35%
1,557,466
-1,057,494
ABVX
14
Abivax
ABVX
$7.7B
$26.7M 2.22%
239,539
-119,766
NERV icon
15
Minerva Neurosciences
NERV
$210M
$26M 2.17%
4,322,747
ACRS icon
16
Aclaris Therapeutics
ACRS
$603M
$25M 2.08%
6,666,666
-2,222,222
ORIC icon
17
Oric Pharmaceuticals
ORIC
$856M
$23.4M 1.95%
1,848,786
-269,598
ANRO icon
18
Alto Neuroscience
ANRO
$753M
$23.3M 1.94%
1,035,551
SNSE icon
19
Sensei Biotherapeutics
SNSE
$17.4M
$22.8M 1.89%
+722,020
AVBP icon
20
ArriVent BioPharma
AVBP
$1.42B
$20.4M 1.7%
+885,916
LBRX
21
LB Pharmaceuticals
LBRX
$815M
$19.7M 1.64%
800,000
MANE
22
Veradermics Inc
MANE
$4.01B
$18.9M 1.57%
+300,000
CAMP icon
23
CAMP4 Therapeutics
CAMP
$218M
$18.7M 1.56%
4,246,568
MLTX icon
24
MoonLake Immunotherapeutics
MLTX
$1.38B
$18.6M 1.55%
1,000,000
DSGN icon
25
Design Therapeutics
DSGN
$685M
$17.2M 1.43%
1,612,903
1
2 3